Skip to main content
Premium Trial:

Request an Annual Quote

Roy Davis

Clinical Genomics has appointed Roy Davis as a senior advisor and board member. Davis is currently a senior advisor for Huron Global Management Consulting and its Innosight subsidiary. He spent 27 years with Johnson & Johnson including separate stints as group president, company group chairman, worldwide franchise chairman, and president of J&J Development Corporation. Davis has also held managing director and general manager roles for Ortho Diagnostics in Europe, Japan, and the Americas. He was the founding president of Veridex, and has served as an innovations advisory board member for Cleveland Clinic.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.